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investor. With this care and interest, the physician should have a strong ally in this
book. As a good amateur's guide to money management and investing, the text will
help anybody with the common sense to realize the limitations ofthe authors' advice.
SUBBA GOLLAMUDI
Medical Student
Yale University School ofMedicine
MONOAMINE INNERVATION OFTHE CEREBRAL CORTEX. Edited by Laurent Descarries,
Tomas R. Reader, and Herbert H. Jasper. New York, Alan R. Liss, Inc., 1984. 361 pp.
No price.
Ifthe brain is the "black box" which holds the biological secrets ofhuman behavior,
then the cerebral cortex is the greatest mystery within the box. Psychiatrists,
neurologists, and neuroscientists, daunted by its complexity, have largely ignored the
cortex in favor of simpler systems. Yet this text, the product of the fifth annual
neuroscience symposium from the Centre de Recherche en Sciences Neurologiques in
Montreal, represents an early effort to develop a framework for understanding the role
ofdiscrete monoamine systems in their innervation ofthe cortex.
One of the current goals of neuroscience is to be able to alter chemically a specific
neural locus or system in a desired manner with the fewest unwanted effects. In this
text, Reader and Jasper review the literature describing the overlap ofmonoamine and
neuropeptide "systems" which holds great potential for selective manipulation of both
cortical and subcortical activity. While their presentation is clear, they emphasize the
excitatory effects ofGABA on noradrenergic systems rather than the direct inhibitory
effect of GABA and benzodiazepines, which have a postulated GABA-potentiating
anxiolytic role at the locus coeruleus. In addition, the physiologic significance of
noradrenergic-peptide interactions is not discussed in depth, while newer peptides such
as neuropeptide Y are ignored.
The potential richness ofthe monoamine-peptide interaction is, however, alluded to
in the chapter by Thierry et al., who note that neurons of the ventral tegmental area
(A10), which provide the dopaminergic innervation of the frontal cortex, also contain
neurotensin and CCK-8, whereas cells of the substantia nigra (A9), which innervate
the striatum, do not contain these peptides. This observation may yet have implications
for the treatment of psychosis. Manipulations of the mesocortical dopaminergic
systems are thought to underlie the antipsychotic action of neuroleptics, while
alterations in the nigrostriatal systems produce the unwanted and debilitating side
effects such as tardive dyskinesia.
In this regard, the electrophysiological literature which is reviewed in the chapters
by Thierry et al. and Bunney and Chiodo offers an alternative strategy for selective
manipulation ofdopaminergic subsystems. These chapters review the literature which
suggests that the mesocortical dopaminergic neurons lack autorecepters and, when
compared to nigrostriatal and mesolimbic systems, exhibit differential sensitivity to
antipsychotic drugs. Such studies also imply that existing antipsychotic medications
begin toexploit thedistribution ofdopamine receptor subclasses toapproach thesortof
selectivity noted above.
Among the other chapters, Iverson describes an intriguing theory in an attempt to
unite recent data concerning the behavioral significance of the locus coeruleus, the
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nuclei ofthe brainstem. In this theory, she attributes to the dorsal noradrenergic (locus
coeruleus) system a role in processing exteroceptive cues; that is, enabling the animal
to respond to significant environmental information. Alternatively, in this theory, the
ventral system (non-locus coeruleus), which provides significant noradrenergic input to
the hypothalamus, plays an interoceptive role crucial for innate motivational states
such as sexual receptiveness in rodents. Such a division could be useful in psychiatry,
perhaps to investigate discrepancies such as the distinction between panic states and
generalized anxiety disorders. There is, however, little evidence to support the
exclusion of the locus coeruleus from interoceptive mediation. In fact, the locus
coeruleus has been implicated in a variety ofappetitive behaviors. Iverson's interesting
chapter may provoke further research to evaluate the behavioral significanceofcentral
noradrenergic systems.
As is often a problem with edited texts, the first two sections of this volume,
"morphology" and "receptors," cover similar material. Despite the overlap, these
sections are highlighted by chapters by Lindvall and Bjorklund, Levitt and his
associates, and Morrison and his collaborators, who collectively describe, as clearly as
possible, the intricate patterns of cortical innervation by noradrenergic, serotonergic,
and dopaminergic systems.
This volume has several chapters which should prove useful to neuroscientists
looking for a collection of reviews of the intricate anatomy of the cortex and its
monoamine innervation. Several chapters also provide useful and simple introductions
to experimental techniques employed in examining morphology and physiology.
Although it is clearly directed toward the basic scientist, clinicians curious as to the
machinations of the "black box" may find this text both stimulating and, as
psychopharmacology progresses, increasingly relevant clinically.
JOHN H. KRYSTAL
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PNEUMOCYSTIS CARINII PNEUMONIA. PATHOGENESIS. DIAGNOSIS. TREATMENT. Ed-
ited by Lowell S. Young. New York, Marcel Dekker, Inc., 1984. 244 pp. $49.75.
This is a nicely printed hardcover book which is Volume 22 of the series "Lung
Biology in Health and Disease." It covers a single infectious disease, pneumonia caused
by the parasite Pneumocystis carinii. This is virtually exclusively an infection seen in
people whose immune system is severely abnormal. Thus, in a clinically relevant text
the infection must be presented in relation to the underlying immune dysfunction. Dr.
Young, himself an expert in this infection and author of three of the eight chapters in
this volume, has assembled a group of experts to write the other chapters, each of
whom has particular expertise in the study of the microorganism or the clinical state
with which this microorganism is associated. One of the important new facets of this
infection is its association with the Acquired Immunodeficiency Syndrome (AIDS),
and there is a chapter on this syndrome and its relationship with Pneumocystis carinii
pneumonia. It is unfortunate that the book is not arranged with other specific chapters
devoted to this infection and its association with malignancy and with congenital
immunodeficiencies. Although there is information about the predisposing factor of
cancer and its treatments, information about congenital immunodeficiency as a
predisposing factor is not covered in any depth.